Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
Intern Med J
; 50(7): 798-804, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-639949
ABSTRACT
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Patient Care Management
/
Inflammatory Bowel Diseases
/
Coronavirus Infections
/
Pandemics
/
Gastroenterology
/
Immunologic Factors
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Oceania
Language:
English
Journal:
Intern Med J
Journal subject:
Internal Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Imj.14889
Similar
MEDLINE
...
LILACS
LIS